AdAdvertisement

Latest News β€” Page 51

methods guide consultation

News

Canada’s Drug Agency Launches Consultation on New Methods Guide for Health Technology Assessments

🧐 How can we improve the transparency of health technology assessments in Canada?

Canada’s Drug Agency has launched a consultation on their first-ever methods guide, aimed at enhancing the evaluation processes for drug reimbursement.

This is a crucial step towards ensuring that evidence-based practices guide our healthcare decisions. Stakeholders are invited to contribute their insights from November 28, 2024, to January 28, 2025.

Learn more about this important initiative!

#SyenzaNews #HealthEconomics #MarketAccess #Healthcare #Innovation

Syenza TeamRead β€Ί
Sanofi 340B rebate model

News

Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Practices

πŸ’‘ Are you curious about how pharmaceutical companies are reforming the 340B program?

Sanofi’s new 340B rebate model aims to combat inefficiencies and abuses within the 340B Drug Pricing Program, aligning with initiatives from Johnson & Johnson and Eli Lilly. This coordinated effort highlights a commitment to transparent and effective care for vulnerable patients. Discover the details on enhancing accountability and improving patient accessibility in healthcare!

#SyenzaNews #pharmaceuticals #HealthcareInnovation #MarketAccess #innovation

Syenza TeamRead β€Ί
mpox healthcare initiatives

News

WHO Acts to Combat Mpox Outbreak: Key Initiatives and Recommendations

🌍 Are you aware of the latest WHO initiatives to combat the mpox outbreak?

The recent update highlights crucial steps taken, including the declaration of a Public Health Emergency of International Concern (PHEIC) and the Emergency Use Listing process for mpox vaccines.

These efforts can significantly enhance access to healthcare products, especially for lower-income countries. Discover how coordinated international support is set to aid the global response to this pressing health challenge.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess #HealthTech

Syenza TeamRead β€Ί
HIV/AIDS global progress

News

Global HIV/AIDS and Sub-Saharan Africa breakthroughs

🌍 How far have we come in the global fight against HIV/AIDS?

A recent study from the Institute for Health Metrics and Evaluation highlights significant progress, especially in Sub-Saharan Africa, where HIV-related deaths and new infections have dramatically declined. However, gaps in access to treatment and persistent challenges, including stigma and gender inequality, remain. Discover the critical insights from this research and what it means for the future of global health.

#SyenzaNews #globalhealth #healthcare #healthcarepolicy #HIVAIDS

Syenza TeamRead β€Ί
MENA health challenges

News

Addressing Physical Inactivity in MENA and Beyond

🌍 Tackling physical inactivity in MENA and globally is crucial! Discover key strategies to meet the 2030 target. Don’t miss out on these critical insights that could shape better health outcomes in the region!

Let’s unite for a healthier future.

#SyenzaNews #HealthForAll #MENA #PhysicalActivity #Healthcare πŸš΄β€β™‚οΈπŸƒβ€β™€οΈ

Syenza TeamRead β€Ί
African pharmaceutical supply chain

News

Smartening Africa’s Drug Supply Chain with IBM AI

🌍 How can advanced technology transform Africa’s pharmaceutical supply chain?

Discover how the Pulse platform, powered by IBM’s AI capabilities, is set to enhance efficiency and transparency in the African drug supply chain. This collaboration aims to address challenges in the market while promoting economic growth and improved health outcomes. Explore the details of this innovative initiative and its impact on access to quality medications across the continent!

#SyenzaNews #AIinHealthcare #DigitalTransformation #Pharmaceuticals #Innovation

Syenza TeamRead β€Ί
Enhancing Primary Health Care Services

News

Enhancing Primary Health Care Services: Strategies and Insights

🌍 Strengthening primary health care is key to better health outcomes! The future of PHC lies in continuous improvement and adaptation. Policymakers must prioritise preventive care, health education, and screening programs. As we move forward, integrating technology and fostering community involvement will be crucial in evolving PHC systems to meet changing needs.

Let’s commit to strengthening primary health care services globally to achieve better health outcomes and universal health coverage. 🌟

#SyenzaNews #PrimaryCare #UniversalHealthCoverage #Healthcare #MENA

Syenza TeamRead β€Ί
global diabetes trends

News

Global Diabetes Trends and Treatment Gaps: 1990-2022 Analysis

🌍 Are we doing enough to tackle the rising global diabetes crisis?

A recent study highlights alarming trends, revealing that the global diabetes prevalence has doubled over the past 30 years, particularly in low- and middle-income countries. With millions untreated, urgent action is needed to bridge the gap in diabetes care. Dive into the findings and explore the critical implications for healthcare policy and access.

#SyenzaNews #GlobalHealth #HealthcareInnovation #HealthForAll #DiabetesCare

Syenza TeamRead β€Ί
South Africa healthcare technology

News

Transforming Healthcare: Key Trends in South African Healthtech

🌍 Are you aware of the exciting transformations in South African healthcare technology?

The sector is booming, fueled by local innovations and international collaborations. Significant investments, like CFAO Healthcare’s acquisition of Sanofi’s Consumer Healthcare business and initiatives such as the Medical Technology Masterplan, are paving the way for a brighter future. Look into the latest trends that are shaping the healthcare landscape!

#SyenzaNews #HealthTech #Innovation #DigitalTransformation #Healthcare

Syenza TeamRead β€Ί
antimicrobial resistance syria

News

Battling Antimicrobial Resistance in Northwest Syria: A Call for Urgent Action

🩺 How can we effectively combat antimicrobial resistance (AMR) in conflict-affected areas like northwest Syria?

Our latest article from the WHO highlights the vital role that healthcare workers play in this battle, emphasising the need for responsible antibiotic use and enhanced training as a game-changer. With World Antimicrobial Awareness Week approaching, it’s crucial to understand both the advantages and challenges posed by antibiotic usage in these regions. 🌍

Read more to discover how we can support these frontline heroes in their fight against AMR.

#SyenzaNews #AntimicrobialResistance #GlobalHealth #Healthcare #NorthwestSyria

Syenza TeamRead β€Ί
biopharma SMEs Europe

News

Boosting Biopharma SMEs in Europe

πŸ’‘ How can we ensure the future of biopharmaceutical SMEs in Europe?

Access to capital and a supportive regulatory environment are critical for the growth and sustainability of these vital enterprises. EFPIA emphasizes the urgent reforms needed to create a thriving ecosystem that retains innovation and skilled labor in Europe.

Jump into our article to explore the challenges and recommendations for empowering biopharma SMEs.

#SyenzaNews #biotechnology #pharmaceuticals #MarketAccess #innovation

Syenza TeamRead β€Ί
universal diabetes care

News

Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy

🌍 Are we doing enough to tackle the diabetes crisis in Europe?

A recent article from Euractiv highlights the urgent need for universal access to diabetes care amidst a growing health challenge affecting millions. With rising cases and a lack of political will, now is the time for action!

Discover the key priorities and recommendations aimed at ensuring equitable care for all individuals living with diabetes.

Read more about how we can advocate for change and improve health outcomes across Europe.

#SyenzaNews #healthcare #universalhealthcoverage #HealthcareInnovation #healthcarepolicy 🌱

Syenza TeamRead β€Ί
340B Drug Pricing Lawsuit

News

Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA

πŸ€” How will ongoing legal battles shape the future of the 340B Drug Pricing Program?

Eli Lilly and Johnson & Johnson are challenging HRSA’s proposed rebate models, arguing that their approaches are essential for enhancing transparency and ensuring discounts directly benefit vulnerable patients. This crucial legal dispute highlights the tensions surrounding drug pricing regulations and could profoundly impact how discounts are provided to covered entities.

Dive into the details of these lawsuits and their implications for the pharmaceutical landscape.

#SyenzaNews #pharmaceuticals #healthcarepolicy #innovation #DrugPricing

Syenza TeamRead β€Ί
WHO Investment Round 2023

News

WHO Investment Round: Securing Funding with Transparency Challenges

🌍 How can global health initiatives thrive with increased funding?

The WHO Investment Round is a pivotal initiative striving to secure $7.1 billion for essential health programs from 2025 to 2028. While achieving 53% of this target via diverse donor engagement, transparency in funding remains a challenge. Discover how these efforts can accelerate progress towards universal health coverage and tackle critical health issues like malaria and cervical cancer!

#SyenzaNews #globalhealth #universalhealthcoverage #healthcare #innovation

Syenza TeamRead β€Ί
HPV vaccination South Africa

News

HPV vaccination South Africa: Cervical Cancer Prevention

🌍 How is South Africa leading the charge against cervical cancer?

Since launching its HPV vaccination program, the country has made remarkable strides in protecting future generations. With impressive coverage rates and a focus on at-risk populations, South Africa serves as a global model for effective public health strategies. Discover how this initiative not only combats cervical cancer but also addresses broader health concerns.

#SyenzaNews #HealthTech #GlobalHealth #HealthcareInnovation #CervicalCancer #HPVVaccination

Syenza TeamRead β€Ί
diabetes diagnosis retinal images

News

Diabetes Diagnosis through Retinal Imaging and Deep Learning

πŸ€” How can deep learning transform diabetes diagnosis?

Discover the innovative DiaNet v2 model, which leverages retinal images to accurately diagnose diabetes with over 92% accuracy! This non-invasive approach has the potential to improve health outcomes, especially in regions where traditional methods are less accessible. Join us in exploring how technology can revolutionise diabetes management.

#SyenzaNews #AIinHealthcare #DigitalHealth #HealthcareInnovation #DiabetesManagement

Syenza TeamRead β€Ί